Fosfomycin as Oral Transition Therapy Versus Continued Intravenous beta-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum beta-Lactamase-Producing Enterobacterales: A Multicenter, Open-Label, Randomized Controlled Trial. (academic.oup.com)

Authors: Seo JW … Kim DM Journal: Clinical Infectious Diseases Published: 2026-06-18 DOI: https://doi.org/10.1093/cid/ciag345